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Abstract 
Background 
According to the most recent CDC statistics, the influenza virus kills between 12,000 and 56,000 
people per year in the United States. Although influenza vaccination is recommended each year, 
only about half of all Americans are actually receiving the vaccine annually. The goal of this 
quality improvement project was to increase influenza vaccination rates at a large academic 
medical center in Kentucky. At baseline, there was no standardized screening protocol in place 
prior to this study.  
Methods 
This study implemented a pre-test post-test design to evaluate the impact of a process change 
intervention on vaccination status from September 1, 2017 to February 28, 2018. Participants for 
this study were taken from the list of all patients currently active at this clinic via the electronic 
medical record. This study was conducted in four phases, using the Plan Do Study Act (PDSA) 
improvement model as a guide. Focus groups were held with clinic staff to establish a process 
change for influenza vaccination. Chart audits were done monthly and changes were made based 
on feedback from clinic staff and vaccination rates.   
Results 
Starting vaccination rates at the clinic were 0.65% in October 2017. The first full month of entire 
clinic compliance with the standardized process was February 1, 2018 to February 28, 2018, with 
vaccination rates of 30.42%. This was a 29.77% increase in vaccination rates during the study 
and a 5.2% increase from the 2016-2017 influenza vaccination rates of 25%.  
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Conclusion 
Through a team based practice improvement process, overall vaccination rates increased at this 
clinic. MACRA reimbursement requirements were achieved at this clinic due to this vaccination 
increase. Creating a standardized screening and vaccination protocol was feasible and effective 
in increasing vaccination rates within this clinic.   
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Background 
The influenza virus is estimated to kill between 12,000-56,000 people each year in the 
United States (CDC, 2017). There are between 9.2 and 36 million cases of influenza in the U.S. 
each year, and between 140,000-710,000 influenza-related hospitalizations (CDC, 2017). 
Although exact numbers of influenza deaths, hospitalizations, and cases are difficult to obtain 
each year due to the mass numbers, comorbidities leading to influenza-associated deaths, and 
missed testing opportunities, the CDC (2018) uses mortality data obtained from the National 
Center for Health Statistics to estimate annual influenza death rates. 
The burden of the influenza virus in the U.S. typically falls from the beginning of 
October through the end of March, with peak activity in December, January, and February 
(CDC, 2018). Influenza activity has been reported through the month of May in previous 
influenza seasons. Since the 2017-2018 influenza season is on track to be one of the worst 
according to the CDC, vaccination is crucial for prevention of falling ill with the influenza virus.   
While there are other important ways to prevent the influenza virus such as handwashing 
and avoiding contact with those who are sick, the most effective strategy for preventing the virus 
is vaccination (CDC, 2017). The CDC recommends all people aged six months and older receive 
the influenza vaccination as the single best way to prevent illness (CDC, 2017). Those who 
cannot receive the influenza vaccine include those younger than six months and those who have 
life-threatening allergies to the vaccine. Vaccination is especially important in those at high risk 
for serious complications from the virus such as children, those who are pregnant or trying to 
become pregnant, those 65 and older, and people with underlying chronic conditions (CDC, 
2017). The influenza virus can be deadly in these populations.  
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The influenza vaccination protects against three or four different strains of the virus, 
depending on the vaccination components. While the influenza vaccination has not been 
especially effective for the 2017-2018 influenza season, the CDC still stresses the importance of 
the influenza vaccine, as it has been shown to decrease the likelihood of hospitalizations and 
deaths from the virus (CDC, 2017). Rates of hospitalizations from the influenza virus are the 
highest on record since 2010, when the CDC began to track hospitalization rates related to 
influenza (CDC, 2017). Not only does receiving the influenza vaccine decrease chances of 
catching the virus, but it also has been shown to decrease severity and duration of symptoms 
(CDC, 2017). Decreasing the severity and duration of symptoms then leads to an overall 
decrease in hospitalizations and deaths from the virus.  
Although the CDC recommends influenza vaccination each year, in the 2016 National 
Health Interview Survey, only 49.9% of those aged 6 months to 17 years, 31.8% of those aged 
18-49, 45.2% of those aged 50-64, and 67.2% of those aged 65 and over reported receiving the 
vaccine in the past twelve months (Clarke, Norris, & Schiller, 2016). This totals to only 48.53% 
of all Americans receiving the influenza vaccination during the past year. Coverage of the spread 
of the influenza virus is rampant on most large news stations, as well as on social media. 
However, despite community knowledge of the rising hospitalizations and deaths from the 
influenza virus, as well as provider recommendation, vaccination rates continue to be low. 
Local Problem 
Kentucky ranks 9th in death rates for influenza and pneumonia in the United States, with 
a death rate of 19.3% (CDC, 2015). Influenza and pneumonia are tied as the 9th leading causes of 
death in Kentucky (CDC, 2015). For the 2017-2018 influenza season, Kentucky is included in 
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the widespread influenza activity currently taking place in the United States, with increasing 
cases, hospitalizations, and deaths on a daily basis (CDC, 2017).  
Kentucky has a 42.6% total reported influenza vaccination rate, which falls below the 
national average of 48.5% (U.S. Department of Health and Human Services, 2018). Fayette 
County has a slightly higher vaccination rate of 54.76% (U.S. Department of Health and Human 
Services, 2018). Kentucky’s low vaccination rates represent a disparity and are attributed to the 
previously mentioned barriers, in addition to access to care and affordability of care (CDC, 
2017).   
The clinic in which this study took place is one of seventeen family medicine clinics 
associated with this large academic center in Kentucky. Prior to initiation of this study, this clinic 
was not meeting MACRA reimbursement requirements for influenza vaccination administration. 
Vaccination rates at this clinic were 25% for the 2016-2017 influenza season. This low 
vaccination rate not only decreased the quality of care received in the clinic, but impacted the 
entire medical center financially. Without increased compliance for vaccination rates, this large 
academic center could lose up to four million dollars in 2019 from penalties from MACRA. 
Barriers to Vaccination 
This low vaccination rate can be attributed to a number of barriers such as a fear of side 
effects, moral or religious objections, limited access to care, and lack of knowledge about the 
vaccine (Ventola, 2016). According to a focus group with staff at this clinic, there are three main 
barriers to vaccination: lack of patient belief in the effectiveness of the vaccine, low staff 
enthusiasm about the vaccine, and patient misconceptions about the vaccine. 
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One of the most common barriers to being vaccinated is the misconception that one can 
catch the influenza virus from the influenza vaccine (Ventola, 2016). This is especially common 
among the young adult population. In a study of college students, Benjamin and Bahr (2016) 
found that nearly 50% of participants believed they would get influenza from receiving the 
vaccine. This barrier can be overcome through patient education regarding the difference 
between a potential immune response from the vaccine and actually being ill with the influenza 
virus (Ventola, 2016).  
Another barrier to vaccination is the patient’s belief in the effectiveness of the influenza 
vaccine. With the CDC estimating 30%-60% effectiveness for the vaccine available for this 
2017-2018 influenza season, many patients feel that there is no point in receiving the vaccine 
(CDC, 2017). Again, this barrier can be overcome through patient education on the 
recommendations for the vaccine, despite its overall effectiveness during any given season. 
Emphasis needs to be placed on the fact that although the vaccine is only 30-60% effective, 
healthy people are dying and no one truly knows how they will respond to the virus.  
The final barrier to vaccination and the barrier that this quality improvement project 
focused on is clinic staff enthusiasm and compliance in screening for and recommending the 
vaccine. Overcoming this barrier was identified by clinic staff as one of the best ways to improve 
vaccination compliance within the clinic. The overall vaccination rate for the 2016-2017 
influenza season at this clinic was 25%. This lack of screening and recommendation often stems 
from a lack of a standardized process, forgetfulness, and increased workflow (Pennant et al., 
2015). Through a standardized vaccination screening and administration process, this barrier can 
be overcome (Ventola, 2016). 
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Purpose 
The purpose of this quality improvement project was to improve the process of 
vaccination administration and to increase vaccination rates at a large academic medical center in 
Kentucky. By implementing a vaccination screening program beginning October 2017, 
vaccination rates were expected to increase by March 2018. Specific aims of this study were: 
1. Evaluate the impact of implementing a vaccination screening program on vaccination rates.  
GOAL: Increase vaccination rates at this clinic to 60% by March 2018. 
2. Evaluate the impact of a team based practice improvement process to increase vaccination 
documentation. 
GOAL: Increase documentation of outside receipt of vaccine or vaccination refusal for this clinic 
to 60% by March 2018.  
Methods 
Context 
This study implemented a pre-test post-test design to evaluate the impact of a process 
change intervention on vaccination status.  
Setting 
This study took place at a large academic medical center in Kentucky. This clinic is one 
of seventeen clinics in association with this academic center and with approximately thirty 
providers, aims to serve a population with diverse needs. IRB approval was obtained prior to 
initiation of this study.  
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Sample 
Participants for this study were selected from family medicine patients at this clinic. All 
patients were included as participants regardless of gender, age, vaccination status, or allergies. 
There was no exclusion of patients based on eligibility for the vaccine or if they were seen at the 
clinic during the time period of this study. The list of patients with documented influenza 
vaccination was obtained via the clinic’s electronic medical record. This data was obtained from 
monthly chart audits of all patients registered as part of the family medicine clinic. The 
compliance rate was obtained by dividing the patients who received the vaccine by all patients in 
the family medicine clinic x 100. There was no incentive for participants to take part in this 
research study. 
Interventions 
This study was conducted in four phases. Using the PDSA model as a guide, focus 
groups were held with clinic staff. The PDSA model is an improvement model that consists of 
planning, doing, studying, and then acting on the results (Institute for Healthcare Improvement, 
2018). Chart audits were done monthly and changes were made based on feedback from clinic 
staff and vaccination rates.   
The team involved in the implementation of this quality improvement project included all 
physicians, nurse practitioners, nurses, and CSTs working at this clinic. Clinical Services 
Technicians (CSTs) are a part of the healthcare team at this clinic and are responsible for the 
administration of vaccinations.  A go-see was completed with CSTs from the red, purple, and 
green teams in September 2017 to assess the current vaccination process at the clinic. A go-see 
was an observation day to assess the CSTs normal workflow. CSTs in this clinic are divided into 
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teams which allow for even distribution between providers. A go-see included observing 
multiple CSTs as they checked the patient in and assessing their process during an entire shift. 
After this original go-see, a current process map was created (See Figure 1). Areas for 
improvement were then identified as a group and a plan for the first PDSA was made.  
Figure 1 
Current Process Flow 
 
Baseline/Current State 
There was no standardized process of vaccination screening at this clinic prior to this 
intervention. After calling the patient from the lobby, CSTs would obtain chief complaint, 
height, weight, vital signs, allergies, and an accurate medication list. Prior to implementation of 
this standardized process, immunization screening was only done if there was time and/or if the 
CST remembered. 
Prior to the start of this quality improvement project, CSTs had no common process for 
immunization screenings and were screening based on personal preference and time per patient. 
This information was obtained via word of mouth from CSTs on the green, red, and purple teams 
at this clinic. There was not common knowledge regarding documentation of outside receipt of 
influenza vaccination or vaccine refusal. 
 
 
Pt arrives
-height/weight
-medications
-vital signs
Ready for provider
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PDSA Cycle 1 
A meeting was then held in September 2017 with CSTs from the green team and a new 
process flow map was developed after identifying areas for improvement. The green team was 
chosen initially to test this intervention on a small scale prior to spreading it to the entire clinic 
until the process was perfected. Starting on a small scale prior to initiation to the entire clinic 
allowed for a changes to be made as barriers were identified. This new process flow map was 
developed and included a clear process for vaccination screening and administration agreed upon 
by both CSTs and providers on the green team. The CSTs would screen for vaccination status 
immediately prior to leaving the room during the patient encounter. A follow-up was then done 
weekly to assess for recommendations for improvements. A second go-see was done in October 
2017 with the green team CSTs to assess flow and compliance. 
PDSA Cycle 2 
The process was evaluated through monthly chart audits of immunization status for the 
clinic and a process meeting with the CSTs. During the go-see in October 2017, a limitation to 
documentation was identified. CSTs were not able to document refusal of vaccination in the 
immunization record; only providers had this capability. This was then brought up with the 
information technology department, but they were not able to resolve the problem during the 
time frame of this study. The information technology department is currently in the process of 
working on a way for CSTs to document refusal of the vaccination. A new process flow map was 
then created, which included communication between CSTs and providers in documentation of 
refusal of the vaccine. This communication was done via a face to face transaction. The provider 
when then document this refusal in their note. Utilizing a new PDSA cycle, this new process 
flow was rolled out on the green team on October 31, 2017. 
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Using this new process, CSTs at this clinic assessed immunization status at the end of 
their patient interaction, prior to provider evaluation of the patient. This new standardized 
protocol then allowed for higher compliance of immunization screening and ability for CSTs to 
vaccinate the patient prior to provider evaluation. Data on vaccination rates were then collected 
via chart audits from November 1, 2017 to November 30, 2017. 
PDSA Cycle 3 
After the chart audit in November 2017, a new process flow map was developed based on 
feedback from the CSTs regarding a barrier to documentation of outside receipt of the influenza 
vaccination. A new process was developed to address this barrier to documentation. CSTs would 
document this outside receipt of the vaccination while they were still in the room with the patient 
to ensure completion, rather than waiting until they had left the room or solely communicating 
this to the provider. This would be documented in the immunization chart in the exact same spot 
as before, but they would click a box detailing “document without ordering.” This would then 
allow for CSTs to document where and when a patient received the vaccine outside of this 
facility. Another chart audit was then obtained from December 1, 2017 to December 31, 2017, 
assessing for influenza vaccination compliance. 
This final process flow map was then ready to be distributed to the entire clinic on 
January 24, 2018 (See Figure 2). The map was distributed to the entire clinic via an educational 
meeting and PowerPoint presentation describing the process flow and assessing for potential 
barriers and areas for improvement. No potential barriers or areas for improvement were 
identified during this meeting. A focus group discussion was held with the CSTs to discuss the 
process. It was agreed upon by the entire family medicine team to implement this process and 
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then continue with regular chart audits to assess the effectiveness of this process. Chart audits 
were then conducted monthly on vaccination rates until February 28, 2018.  
Figure 2 
New Process Flow 
 
  
 
 
Measures (see Table 1): The measures for this study were: 
1. Demographics: Age in years, gender, ethnicity, and vaccination status of patients were 
obtained from the patient charts 
2. Vaccination rates: Vaccination rates were based on clinic staff documentation of providing a 
vaccination to patients within the specified time. There was only one allotted spot for 
immunization documentation in the electronic medical record. Individuals receiving the 
vaccination were coded as ‘1’ and those not receiving the vaccination were coded as ‘0’. A 
ratio of those receiving vaccinations were calculated by dividing the number of those who 
received vaccinations over the eligible population times 100. 
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Table 1.  
Study Measures 
Measures  Description  Level of 
Measurement  
Analysis Data Source 
Age Age in years Interval/Ratio Means(SD), t-tests Medical Records 
Gender Male vs Female Nominal  Frequencies (%), 
Chi-Square 
Medical Records 
Ethnicity  White, Black, 
Hispanic, Indian, 
Native American, 
Mixed Race, Middle 
Easter, Asian, Other 
Nominal  Frequencies (%), 
Chi-Square 
Medical Records 
Active 
Problem 
Diagnosis made by 
primary care 
provider 
Nominal Frequencies (%), 
Chi-Square 
Medical Records 
Vaccination 
Rates 
Number who 
received 
vaccinations/number 
eligible X 100 
Interval/ratio  Independent sample 
t-test 
Medical Records 
   
Analysis 
Vaccination rates at this clinic were obtained from monthly chart audits utilizing the 
electronic medical record. Rates were described in percentages based on the number of patients 
established in the family medicine clinic vs the number of patients whose current influenza 
immunization status was documented. This study was not able to discriminate between who was 
eligible for the influenza vaccination vs who was not eligible during these chart audits. This 
uncontrollable data included immunocompromised patients and patients with allergies to the 
vaccine who would have a contraindication to the vaccine.    
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Results 
PDSA Cycle 1 
Continuous cycles of change were completed to improve vaccination rates. New cycles 
were initiated based on feedback from clinic staff and vaccination rates. Baseline data for this 
quality improvement project were obtained October 2017 after initiation of the standardized 
protocol on the green team. Beginning influenza vaccination rates at this clinic were 0.65%. 
PDSA Cycle 2 
During the go-see in the middle of October 2017, a limitation to documentation was 
identified. A second PDSA cycle was initiated, adding the verbal communication between CSTs 
and providers of patient refusal of the influenza vaccine. The new process flow map was rolled 
out to the green team on October 31, 2017. Data on vaccination rates were then collected from 
the green team via chart audits from November 1, 2017 to November 30, 2017. Vaccination rates 
at this time increased to 12.4%.  
PDSA Cycle 3 
Based on feedback obtained from the green team CSTs, a new process flow map was 
created in November 2017. This new flow map included documentation of outside receipt of the 
vaccine while the CST was still in the room with the patient. This outside receipt of the vaccine 
was charted in the same place that they would chart administration of the vaccine. A second 
chart audit was obtained from this same medical team from December 1, 2017 to December 31, 
2017. Vaccination rates increased to 25.74% during this time.  
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The final process flow map was implemented in the entire clinic on January 23, 2018 and 
immunization rates for January 1, 2018 to January 31, 2018 were 30.03%. The first full month of 
entire clinic compliance with standardized process began February 1, 2018. Immunization rates 
for February 1, 2018 to February 28, 2018 were 30.42%. (See Figure 3) Immunization rates were 
then compared to the same time period from the previous year.  
Figure 3 
Immunization Rates  
 
Discussion 
Through a team based practice improvement process, overall vaccination rates increased 
in this primary care clinic. Comparison of the 2016-2017 to the 2017-2018 vaccination rates 
showed a 5.2% increase after initiation of this standardized protocol. This percentage was 
determined to be statistically significant through a chi-square test where the p-value <0.001. 
Creating a standardized screening and vaccination protocol was feasible and effective in 
increasing vaccination rates within this clinic.  
Similar quality improvement projects have been published and also suggest an increase in 
vaccination rates based on changing clinic procedures and recommendations (Stone, 2002 and 
Parker et al, 2013). With a change in clinic procedures and recommendations, vaccination rates 
0 5 10 15 20 25 30 35
October 1-31
November 1-30
December 1-31
January 1-31
February 1-28
Vaccination Rates 2017-2018 Influenza Season
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increased as a result. In a meta-analysis of 108 articles related to prevention strategies, 
interventions such as organizational change of clinic procedures proved to be the best ways to 
increase vaccinations and screenings (Stone, 2002).  In a quality improvement project by Parker 
et al. (2013), vaccination compliance was increased over a ten week period through the use of a 
screening questionnaire and process change for HPV vaccination. Vaccination rates can be 
increased significantly through process change utilizing an improvement model such as the 
PDSA and data evaluation.  
As a part of continuing quality improvement, this clinic has adopted this screening 
protocol as standard procedure and will continue to use this influenza vaccination screening 
process. This screening process can also be used in the future for other recommended vaccines. 
This process can be improved through the use of automatic electronic medical record reminders 
regarding overdue vaccinations in the patient’s chart. These automated reminders are currently 
being developed by the information technology work group at this clinic.  
Resistance to change was evident while observing CST compliance with the process 
change. The CSTs did not think that they would have the time to initiate this screening protocol 
into their busy schedule. Utilizing Prosci’s Best Practices in Change Management (2018), this 
resistance to change was anticipated and we were proactive in managing the resistance. We used 
Lewin’s change theory to combat this resistance and prepare CSTs for this change (Petiprin, 
2016; See Figure 4). Education was provided to the CSTs on how long the process would take 
and how it could best be integrated into their busy schedules. Although there was major 
resistance in the beginning, this was overcome once CSTs realized this change could easily fit 
into their schedules. The CSTs were also involved in identifying barriers to the process and 
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changing the process as necessary. Although there was an attempt to overcome this barrier, 
resistance to change could have been a factor in the overall vaccination results.  
Figure 4 
Lewin’s Change Theory 
 
 
Limitations  
A limitation identified in this study was the lack of ability of the CSTs to document 
vaccination refusal in the electronic medical record. Although the information technology work 
group is currently addressing this issue, they were not able to resolve it during the study. This 
inability to document refusal led to an overall decrease in the vaccination percentages, as the 
number of patients who refused should have been taken out of the number of patients eligible for 
the vaccination. There was no way to establish eligibility and account for this via vaccination 
rates in this study. 
One factor that contributed to the increase in influenza vaccination during this study is 
the commonality of vaccination rates increasing as the influenza season progresses. It was 
expected that our beginning number would be low and that this number would rise throughout 
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the influenza season, despite intervention. Although this could have been a contributing factor, it 
is clear that intervention played a strong role in increasing these rates as there was a 5.2% 
increase in vaccination rates from the 2016-2017 influenza season.  
Practice Recommendations  
While there was a significant increase in vaccination rates from the 2016-2017 influenza 
season, overall clinic and enterprise goal of obtaining 60% vaccination rates for the 2017-2018 
influenza season was not met during this study. It is projected that this goal could eventually be 
met by continually educating patients on the importance of the influenza vaccine and ensuring 
healthcare staff compliance with the vaccination process. Special influenza vaccine clinics could 
be held prior to the start of the influenza season at the clinic to increase initial rates. This special 
influenza vaccine clinic could be a way to reach patients who would not otherwise have a visit 
during the influenza season. Vaccination rates should still be monitored for the upcoming 
influenza seasons. This process can also be applied to all other vaccination rates. In order to 
apply this successfully to other vaccination rates, patient eligibility would have to be previously 
established in the electronic medical record.  
It is also recommended that the inability to document refusal of the vaccine by CSTs be 
resolved by the information technology work group. If CSTs have the ability to document refusal 
of the vaccine, this will increase clinic compliance rates with vaccination percentages by taking 
away from those eligible for the vaccine. This increase in clinic compliance with vaccine 
administration will then aid in MACRA reimbursement for the entire academic medical center.  
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Practice Implications  
This increase in influenza vaccination rates will improve quality of care within this clinic. 
Patients will have a decreased risk of becoming ill with the influenza virus, thus decreasing their 
risk for hospitalizations and death from the virus. This increase in vaccination rates will improve 
both patient quality of care and patient health outcomes. 
Additionally, increasing the influenza vaccination rates will also help this clinic achieve 
Medicare Access and CHIP Reauthorization Act (MACRA) requirements for reimbursement. 
Through a standardized process of documentation, immunization data are able to be captured for 
MACRA reimbursement. With electronic medical record changes allowing for documentation of 
refusal of the vaccine, the clinic will be able to also use these refusals for MACRA 
reimbursement. This increase in vaccination rates will also allow this clinic to maintain their 
Patient Centered Medical Home (PCMH) accreditation.   
Conclusion 
The initiation of a standardized vaccination screening and administration protocol 
increased vaccination rates at this clinic. Through the continued use of this standardized 
vaccination process, influenza vaccination rates are expected to continue to rise for upcoming 
influenza seasons. Although this project was effective, there is more work to be done to continue 
to increase vaccination rates in the future and meet the goal of a 60% influenza vaccination rate 
at this clinic.  
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